Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition

Own work on HL is funded by the Deutsche Forschungsgemeinschaft (SFB 1530, C01). Open access funding enabled and organized through project DEAL. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.

Authors

Institutions

Publication Details

Journal
Signal Transduction and Targeted Therapy
Published
2024-09-23
DOI
https://doi.org/10.1038/s41392-024-01968-0
Citations
1
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition

Ralf Küppers, Marc A. Weniger
1 citations
Signal Transduction and Targeted Therapy
Lymphoma Diagnosis and Treatment
0.42
article

Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition

Ralf Küppers, Marc A. Weniger
article en
1 citations

Abstract

Own work on HL is funded by the Deutsche Forschungsgemeinschaft (SFB 1530, C01). Open access funding enabled and organized through project DEAL. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.

Signal Transduction and Targeted TherapyVol. 9(1)
University of Duisburg-Essen (DE)
Deutsche Forschungsgemeinschaft, Universität Duisburg-Essen
Zero hunger
Openalex Percentile: Top 35%
Lymphoma Diagnosis and Treatment
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.